{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:17:25Z","timestamp":1793038645100,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberculin skin test and interferon-gamma release assay are not good at differentiating active tuberculosis from latent tuberculosis. Interferon-gamma-induced protein 10 (IP-10) has been widely used to detect tuberculosis infection. However, its values of discriminating active and latent tuberculosis is unknown. To estimate the diagnostic potential of IP-10 for differentiating active tuberculosis from latent tuberculosis, we searched PubMed, Web of Science, Embase, the Cochrane Library, CNKI, Wanfang, VIP and CBM databases. Eleven studies, accounting for 706 participants (853 samples), were included. We used a bivariate diagnostic random-effects model to conduct the primary data. The overall pooled sensitivity, specificity, negative likelihood rate, positive likelihood rate, diagnostic odds ratio and area under the summary receiver operating characteristic curve were 0.72 (95% CI: 0.68\u20130.76), 0.83 (95% CI: 0.79\u20130.87), 0.32 (95% CI: 0.22\u20130.46), 4.63 (95% CI: 2.79\u20137.69), 17.86 (95% CI: 2.89\u201338.49) and 0.8638, respectively. This study shows that IP-10 is a potential biomarker for differentiating active tuberculosis from latent tuberculosis.<\/jats:p>","DOI":"10.1038\/s41598-019-47923-w","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T10:22:49Z","timestamp":1565086969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis"],"prefix":"10.1038","volume":"9","author":[{"given":"Xia","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"47923_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tube.2015.12.007","volume":"97","author":"T Chen","year":"2016","unstructured":"Chen, T. et al. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array. Tuberculosis 97, 108\u2013117, https:\/\/doi.org\/10.1016\/j.tube.2015.12.007 (2016).","journal-title":"Tuberculosis"},{"issue":"4","key":"47923_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jinf.2017.07.004","volume":"75","author":"Raquel Villar-Hern\u00e1ndez","year":"2017","unstructured":"Villar-Hernandez, R. et al. Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases. J Infect. 75, 315\u2013325, 310.1016\/j.jinf.2017.1007.1004. Epub 2017 Jul 1025 (2017).","journal-title":"Journal of Infection"},{"key":"47923_CR3","doi-asserted-by":"crossref","unstructured":"Alsdurf, H., Hill, P. C., Matteelli, A., Getahun, H. & Menzies, D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 16, 1269\u20131278, 1210.1016\/S1473-3099(1216)30216-X. Epub 32016 Aug 30210 (2016).","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"47923_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tube.2016.06.001","volume":"102","author":"J Wu","year":"2017","unstructured":"Wu, J. et al. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection. Tuberculosis 102, 68\u201375, https:\/\/doi.org\/10.1016\/j.tube.2016.06.001 (2017).","journal-title":"Tuberculosis"},{"key":"47923_CR5","doi-asserted-by":"publisher","unstructured":"Nonghanphithak, D., Reechaipichitkul, W., Namwat, W., Naranbhai, V. & Faksri, K. Chemokines additional to IFN-gamma can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype. Tuberculosis (Edinb). 105, 28\u201334, https:\/\/doi.org\/10.1016\/j.tube.2017.1004.1005 Epub 2017 Apr 1018 (2017).","DOI":"10.1016\/j.tube.2017.1004.1005"},{"issue":"9","key":"47923_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2016.10357","volume":"316","author":"Leila C. Kahwati","year":"2016","unstructured":"Kahwati, L. C. et al. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 316, 970\u2013983, 910.1001\/jama.2016.10357 (2016).","journal-title":"JAMA"},{"key":"47923_CR7","first-page":"353","volume":"11","author":"JS Friedland","year":"2011","unstructured":"Friedland, J. S. Tuberculosis in the 21st century. Clinical Medicine, Journal of the Royal College of Physicians of London 11, 353\u2013357 (2011).","journal-title":"Clinical Medicine, Journal of the Royal College of Physicians of London"},{"issue":"4","key":"47923_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","volume":"192","author":"Marc Tebruegge","year":"2015","unstructured":"Tebruegge, M. et al. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis. Am J Respir Crit Care Med. 192, 485\u2013499, 410.1164\/rccm.201501-200059OC (2015).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"47923_CR9","doi-asserted-by":"crossref","unstructured":"Chegou, N. N., Heyckendorf, J., Walzl, G., Lange, C. & Ruhwald, M. Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J. 43, 1472\u20131486, 1410.1183\/09031936.00151413. Epub 09032013 Dec 09031935 (2014).","DOI":"10.1183\/09031936.00151413"},{"key":"47923_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3899\/jrheum.130074","volume":"41","author":"D Goletti","year":"2014","unstructured":"Goletti, D., Sanduzzi, A. & Delogu, G. Performance of the tuberculin skin test and interferon-g release assays: An update on the accuracy, cutoff stratification, and new potential immune-based approaches. Journal of Rheumatology 41, 24\u201331 (2014).","journal-title":"Journal of Rheumatology"},{"key":"47923_CR11","first-page":"S32","volume":"14","author":"N Chegou","year":"2010","unstructured":"Chegou, N. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: Preliminary report. International Journal of Tuberculosis and Lung Disease 14, S32\u2013S34 (2010).","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"47923_CR12","doi-asserted-by":"crossref","unstructured":"Wergeland, I., Assmus, J. & Dyrhol-Riise, A. M. Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls. PLoS One. 11, e0163848, 0163810.0161371\/journal.pone.0163848. eCollection 0162016 (2016).","DOI":"10.1371\/journal.pone.0163848"},{"issue":"11","key":"47923_CR13","doi-asserted-by":"publisher","first-page":"e79742","DOI":"10.1371\/journal.pone.0079742","volume":"8","author":"Yun-Gyoung Hur","year":"2013","unstructured":"Hur, Y. G. et al. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults. PLoS One. 8, e79742, 79710.71371\/journal.pone.0079742. eCollection 0072013 (2013).","journal-title":"PLoS ONE"},{"issue":"2","key":"47923_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1183\/09031936.00129412","volume":"42","author":"Martine G. Aabye","year":"2013","unstructured":"Aabye, M. G. et al. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J. 42, 495\u2013503, 410.1183\/09031936.00129412. Epub 09032013 Jan 09031924 (2013).","journal-title":"European Respiratory Journal"},{"issue":"1 Supplement 1","key":"47923_CR15","first-page":"S125","volume":"33","author":"A Ajayan","year":"2017","unstructured":"Ajayan, A., Nangia, A., Singh, V. & Sindhwani, S. P. To study the serum levels of pro-inflammatory and anti-inflammatory cytokines in pediatric tuberculosis. Indian Journal of Hematology and Blood Transfusion 33(1 Supplement 1), S125 (2017).","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"key":"47923_CR16","doi-asserted-by":"crossref","unstructured":"Ruhwald, M., Aabye, M. G. & Ravn, P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn. 12, 175\u2013187, 110.1586\/erm.1511.1597 (2012).","DOI":"10.1586\/erm.11.97"},{"issue":"2","key":"47923_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/JCM.02758-14","volume":"53","author":"Yun Hee Jeong","year":"2014","unstructured":"Jeong, Y. H. et al. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production. J Clin Microbiol. 53, 504\u2013510, 510.1128\/JCM.02758-02714. Epub 02014 Nov 02726 (2015).","journal-title":"Journal of Clinical Microbiology"},{"key":"47923_CR18","doi-asserted-by":"publisher","unstructured":"Yao, X. et al. Multiplex analysis of plasma cytokines\/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants. Tuberculosis (Edinb). 107, 88\u201394, https:\/\/doi.org\/10.1016\/j.tube.2017.1007.1013. Epub 2017 Aug 1013 (2017).","DOI":"10.1016\/j.tube.2017.1007.1013."},{"issue":"4","key":"47923_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jinf.2014.12.019","volume":"70","author":"I. Wergeland","year":"2015","unstructured":"Wergeland, I. et al. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. J Infect. 70, 381\u2013391, 310.1016\/j.jinf.2014.1012.1019. Epub 2015 Jan 1015 (2015).","journal-title":"Journal of Infection"},{"key":"47923_CR20","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1128\/cvi.00499-14","volume":"21","author":"QT Yang","year":"2014","unstructured":"Yang, Q. T. et al. IP-10 and MIG Are Compartmentalized at the Site of Disease during Pleural and Meningeal Tuberculosis and Are Decreased after Antituberculosis Treatment. Clinical and Vaccine Immunology 21, 1635\u20131644, https:\/\/doi.org\/10.1128\/cvi.00499-14 (2014).","journal-title":"Clinical and Vaccine Immunology"},{"issue":"5","key":"47923_CR21","doi-asserted-by":"publisher","first-page":"e64226","DOI":"10.1371\/journal.pone.0064226","volume":"8","author":"Novel N. Chegou","year":"2013","unstructured":"Chegou, N. N. et al. Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS One. 8, e64226, 64210.61371\/journal.pone.0064226. Print 0062013 (2013).","journal-title":"PLoS ONE"},{"issue":"3","key":"47923_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","volume":"74","author":"Eun-Jeong Won","year":"2017","unstructured":"Won, E. J. et al. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease. J Infect. 74, 281\u2013293, 210.1016\/j.jinf.2016.1011.1010. Epub 2016 Nov 1019 (2017).","journal-title":"Journal of Infection"},{"key":"47923_CR23","unstructured":"Wang, S. Screening of novel tuberculosis diagnostic antigens and biomarkers and their application in the diagnosis of tuberculosis. Fudan University. (2012)."},{"key":"47923_CR24","first-page":"34","volume":"26","author":"XF Li","year":"2016","unstructured":"Li, X. F. et al. Application of combined CKs to differentiate active and latent tuberculosis infection. Chinese Journal of Modern Medicine. 26, 34\u20139 (2016).","journal-title":"Chinese Journal of Modern Medicine."},{"issue":"3","key":"47923_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1473-3099(16)30474-1","volume":"17","author":"Helen E Jenkins","year":"2017","unstructured":"Jenkins, H. E. et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 17, 285\u2013295, 210.1016\/S1473-3099(1016)30474-30471. Epub 32016 Dec 30478 (2017).","journal-title":"The Lancet Infectious Diseases"},{"issue":"6","key":"47923_CR26","doi-asserted-by":"publisher","first-page":"e1568","DOI":"10.1542\/peds.2014-1570","volume":"134","author":"Line Lindebo Holm","year":"2014","unstructured":"Holm, L. L. et al. A comparison of interferon-gamma and IP-10 for the diagnosis of tuberculosis. Pediatrics. 134, e1568\u20131575, 1510.1542\/peds.2014-1570 (2014).","journal-title":"Pediatrics"},{"key":"47923_CR27","doi-asserted-by":"crossref","unstructured":"Auguste, P. et al. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 17, 200, 210.1186\/s12879-12017-12301-12874 (2017).","DOI":"10.1186\/s12879-017-2301-4"},{"key":"47923_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep09223.","volume":"5","author":"K Tonby","year":"2015","unstructured":"Tonby, K., Ruhwald, M., Kvale, D. & Dyrhol-Riise, A. M. IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection. Sci Rep. 5, 9223, https:\/\/doi.org\/10.1038\/srep09223. (2015).","journal-title":"Sci Rep."},{"key":"47923_CR29","first-page":"34513","volume":"7","author":"L Petrone","year":"2018","unstructured":"Petrone, L. et al. First description of agonist and antagonist IP-10 in urine of patients with active TB. Int J Infect Dis 7, 34513\u201334512 (2018).","journal-title":"Int J Infect Dis"},{"key":"47923_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmi.2018.12.006","volume":"25","author":"X Qiu","year":"2018","unstructured":"Qiu, X. et al. Accuracy of interferon-\u03b3-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis. Clin Microbiol Infect. 25, 667\u2013672, https:\/\/doi.org\/10.1016\/j.cmi.2018.12.006 (2018).","journal-title":"Clin Microbiol Infect."},{"key":"47923_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","volume":"73","author":"E Petruccioli","year":"2016","unstructured":"Petruccioli, E. et al. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. Journal of Infection. 73, 588\u2013597, https:\/\/doi.org\/10.1016\/j.jinf.2016.09.008 (2016).","journal-title":"Journal of Infection."},{"key":"47923_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tube.2018.06.005","volume":"111","author":"L Petrone","year":"2018","unstructured":"Petrone, L. et al. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis. 111, 147\u2013153, https:\/\/doi.org\/10.1016\/j.tube.2018.06.005 (2018).","journal-title":"Tuberculosis."},{"key":"47923_CR33","doi-asserted-by":"crossref","unstructured":"Kabeer, B. S., Sikhamani, R. & Raja, A. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS. 24, 323\u2013325, 310.1097\/QAD.1090b1013e328334895e (2010).","DOI":"10.1097\/QAD.0b013e328334895e"},{"issue":"9","key":"47923_CR34","doi-asserted-by":"publisher","first-page":"e12577","DOI":"10.1371\/journal.pone.0012577","volume":"5","author":"Delia Goletti","year":"2010","unstructured":"Goletti, D. et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One. 5, e12577, 12510.11371\/journal.pone.0012577 (2010).","journal-title":"PLoS ONE"},{"key":"47923_CR35","doi-asserted-by":"publisher","unstructured":"Vanini, V. et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect. 65, 49\u201359, https:\/\/doi.org\/10.1016\/j.jinf.2012.1003.1017. Epub 2012 Mar 1029 (2012).","DOI":"10.1016\/j.jinf.2012.1003.1017."},{"key":"47923_CR36","doi-asserted-by":"publisher","unstructured":"Knobloch, K., Yoon, U. & Vogt, P. M. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg. 39, 91\u201392, https:\/\/doi.org\/10.1016\/j.jcms.2010.1011.1001. Epub 2010 Dec 1019 (2011).","DOI":"10.1016\/j.jcms.2010.1011.1001."},{"issue":"8","key":"47923_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"Penny F. Whiting","year":"2011","unstructured":"Whiting, P. F. et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 155, 529\u2013536, 510.7326\/0003-4819-7155-7328-201110180-201100009 (2011).","journal-title":"Annals of Internal Medicine"},{"key":"47923_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-1186-1131","volume":"6","author":"J Zamora","year":"2006","unstructured":"Zamora, J., Abraira, V., Muriel, A., Khan, K. & Coomarasamy, A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 6, 31, https:\/\/doi.org\/10.1186\/1471-2288-1186-1131 (2006).","journal-title":"BMC Med Res Methodol."},{"key":"47923_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-2-9","volume":"2","author":"WL Deville","year":"2002","unstructured":"Deville, W. L. et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2, 9 (2002).","journal-title":"BMC Med Res Methodol."},{"issue":"5","key":"47923_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0272989X08319957","volume":"28","author":"L.R. Arends","year":"2008","unstructured":"Arends, L. R. et al. Bivariate random effects meta-analysis of ROC curves. Med Decis Making. 28, 621\u2013638, 610.1177\/0272989X08319957. Epub 08312008 Jun 08319930 (2008).","journal-title":"Medical Decision Making"},{"key":"47923_CR41","doi-asserted-by":"crossref","unstructured":"Chappell, F. M., Raab, G. M. & Wardlaw, J. M. When are summary ROC curves appropriate for diagnostic meta-analyses? Stat Med. 28, 2653\u20132668, 2610.1002\/sim.3631 (2009).","DOI":"10.1002\/sim.3631"},{"key":"47923_CR42","doi-asserted-by":"crossref","unstructured":"Deeks, J. J., Macaskill, P. & Irwig, L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 58, 882\u2013893, 810.1016\/j.jclinepi.2005.1001.1016 (2005).","DOI":"10.1016\/j.jclinepi.2005.01.016"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47923-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:21:28Z","timestamp":1671279688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47923-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47923"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47923-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11408"}}